Sargent v. Atrium Medical Corporation

CourtDistrict Court, D. New Hampshire
DecidedSeptember 19, 2019
Docket1:17-cv-00740
StatusUnknown

This text of Sargent v. Atrium Medical Corporation (Sargent v. Atrium Medical Corporation) is published on Counsel Stack Legal Research, covering District Court, D. New Hampshire primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sargent v. Atrium Medical Corporation, (D.N.H. 2019).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW HAMPSHIRE

Crystal D. Sargent

v. Civil No. 17-cv-740 -LM Opinion No. 2019 DNH 160 Atrium Medical Corporation, Maquet Cardiovascular US Sales, LLC, and Getinge AB

In re: Atrium Medical Corp. C-QUR Mesh Products Liability Litigation (MDL No. 2753)

O R D E R Crystal Sargent brings suit against Atrium Medical Corporation (“Atrium”), a medical device company that manufactured and sold C-QUR mesh, and two related companies, Maquet Cardiovascular US Sales, LLC (“Maquet”) and Getinge AB (“Getinge”), alleging product liability claims and breach of warranty claims. Sargent’s suit is part of a multi-district litigation (“MDL”) proceeding involving claims that C-QUR mesh was, among other things, defective and unreasonably dangerous and caused injury when surgically implanted for hernia repair. The case was selected in the MDL proceeding for the Initial Discovery Pool, making it a bellwether case. Defendants Atrium and Maquet move to dismiss on a variety of grounds.1 Sargent objects.

1 Getinge has filed a separate motion to dismiss in the main MDL case contending that the court lacks personal jurisdiction over it. That motion remains pending. Getinge does not join in the instant motion. STANDARD OF REVIEW Under Rule 12(b)(6), the court must accept the factual allegations in the complaint as true, construe reasonable inferences in the plaintiff’s favor, and “determine whether the factual allegations in the plaintiff’s complaint set forth a plausible claim upon which relief may be granted.” Foley v. Wells Fargo Bank, N.A., 772 F.3d 63, 71 (1st Cir. 2014) (internal quotation

marks omitted). A claim is facially plausible “when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009).

BACKGROUND Sargent lived in Alabama during the events at issue in this case, and still lives there. Sargent had surgery on July 23, 2012, at University of South Alabama Medical Center in Mobile, Alabama, to repair a ventral hernia. Sargent’s physicians used a piece of C-QUR mesh to repair the hernia. On April 14, 2014, Sargent went back to the Medical Center because her hernia had

recurred. She underwent another surgery to repair the hernia. During the operation it was found that omentum and bowel were adhesed to Sargent’s mesh, which also had significant scar tissue. Atrium, which designed, marketed, and sold the C-QUR mesh that was implanted into Sargent, is located in New Hampshire. Maquet is located in New Jersey, and Getinge is a Swedish corporation. Sargent alleges that Maquet and Getinge are responsible for Atrium’s actions and exercised control over Atrium with respect to oversight and compliance with applicable safety standards. Sargent alleges, among other things, that defendants designed, manufactured, marketed, and sold C-QUR mesh to be used by surgeons for hernia repair. C-QUR mesh was intended to be permanently implanted for those repairs, and defendants represented that C-QUR mesh was safe and effective for that purpose. She further alleges that C-QUR mesh was not safe or effective for its intended purpose, that defendants failed to adequately research and test it to

determine the risks and benefits of the mesh, and that they failed to warn of risks although they had been notified that the mesh was causing widespread catastrophic complications. Sargent alleges claims of negligence (Count I), strict liability – design defect (Count II), strict liability – manufacturing defect (Count III), strict liability – failure to warn (Count IV), breach of express warranty (Count V), breach of implied warranties of merchantability and fitness of purpose (Count VI), and punitive damages (Count VII).

DISCUSSION Defendants Atrium and Maquet move to dismiss Sargent’s claims, contending that they

are barred by the applicable statutes of limitations, that Alabama law applies to liability, and that the strict liability claims (Counts II-IV) are not cognizable under Alabama law. Defendants also contend that Sargent’s claim for punitive damages must be dismissed because it does not state a cause of action. Sargent objects, arguing that her claims are not time-barred, that New Hampshire law applies to her claims, and that her claims are sufficiently pleaded.

I. Statute of Limitations The parties agree that New Hampshire’s statutes of limitations, as procedural rules of the forum state, apply in this case. See TIG Ins. Co. v. EIFlow Ins. Ltd., No. 14-cv-459-JL, 2015 WL 5714686, at *3 (D.N.H. Sept. 29, 2015) (discussing circumstances under which it is appropriate for this court, sitting in diversity, to apply New Hampshire’s statute of limitations). They further agree that Sargent’s product liability claims, Counts I through IV, are governed by RSA 508:4, I, and the breach of warranty claims, Counts V and VI, are governed by RSA 382- A:2-725.

A. Product Liability Claims Under New Hampshire law, “[e]xcept as otherwise provided by law, all personal actions, . . . may be brought only within 3 years of the act or omission complained of.” RSA 508:4, I. An exception to that time limit exists when the injury and its causal relationship to the act or omission were not discovered and could not reasonably have been discovered at the time of the act or omission, the action shall be commenced within 3 years of the time the plaintiff discovers, or in the exercise of reasonable diligence should have discovered, the injury and its causal relationship to the act or omission complained of.

RSA 508:4, I. If the defendant meets the initial burden of showing that the action was not brought within three years of the underlying events, to avoid dismissal, the plaintiff must show that the discovery rule or another tolling doctrine, such as the fraudulent concealment rule, applies. Beane v. Dana S. Beane & Co., P.C., 160 N.H. 708, 712 (2010). “[T]he fraudulent concealment rule states that when facts essential to the cause of action are fraudulently concealed, the statute of limitations is tolled until the plaintiff has discovered such facts or could have done so in the exercise of reasonable diligence.” Bricker v. Putnam, 128 N.H. 162, 165 (1986). The equitable purpose of the fraudulent concealment rule in tolling the limitations period is to prevent the wrongdoer from receiving and keeping the benefit of its fraudulent conduct. Lakeman v. LaFrance, 102 N.H. 300, 303 (1959). Similarly, the doctrine of equitable tolling delays the limitations deadline when the plaintiff “was prevented in some extraordinary way from exercising his or her rights.” Portsmouth Country Club v. Town of Greenland, 152 N.H. 617, 623 (2005). Defendants argue that Sargent’s product liability claims are time-barred because the mesh was implanted in July 2012, which is more than three years before she brought this action. In

response, Sargent invokes the protection of the discovery rule and the doctrines of fraudulent concealment and equitable tolling. She alleges that defendants concealed the defective design of the C-QUR mesh that was implanted to repair her hernia and that they misled physicians and surgeons about the mesh product’s efficacy and serious complications.2 See, e.g., doc. no. 63 at ¶¶ 34, 49, 50, 51, 52, 55, 56, 63, 114, 116, 118, 122, 128, 132, 154, 155, 156, & 157. “The district court may grant a motion to dismiss based on a defendant’s affirmative defense of a statute of limitations when the pleader’s allegations leave no doubt that an asserted claim is time-barred.” DeGrandis v. Children’s Hosp.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Rodi v. Southern New England School of Law
389 F.3d 5 (First Circuit, 2004)
Lockheed Martin Corp. v. RFI Supply, Inc.
440 F.3d 549 (First Circuit, 2006)
United States v. Ilario M.A. Zannino
895 F.2d 1 (First Circuit, 1990)
Dennis v. American Honda Motor Co.
585 So. 2d 1336 (Supreme Court of Alabama, 1991)
Lakeman v. LaFrance
156 A.2d 123 (Supreme Court of New Hampshire, 1959)
Beane v. Dana S. Beane & Co., P.C.
7 A.3d 1284 (Supreme Court of New Hampshire, 2010)
Stupak v. Hoffman-La Roche, Inc.
287 F. Supp. 2d 968 (E.D. Wisconsin, 2003)
SIG Arms Inc. v. Employers Insurance of Wausau
122 F. Supp. 2d 255 (D. New Hampshire, 2000)
Foley v. Wells Fargo Bank, N.A.
772 F.3d 63 (First Circuit, 2014)
DeGrandis v. Children's Hospital Boston
806 F.3d 13 (First Circuit, 2015)
Bricker v. Putnam
512 A.2d 1094 (Supreme Court of New Hampshire, 1986)
Portsmouth Country Club v. Town of Greenland
883 A.2d 298 (Supreme Court of New Hampshire, 2005)
Kelleher v. Marvin Lumber & Cedar Co.
891 A.2d 477 (Supreme Court of New Hampshire, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
Sargent v. Atrium Medical Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sargent-v-atrium-medical-corporation-nhd-2019.